National Capital Daily
SEE OTHER BRANDS

The top news stories from Washington, D.C.

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on National Capital Daily.

Uncovered Long-Hidden U.S. Resource Reserve In Resurfaced Presentation from Former White House Advisor That Could Quietly Reshape Trump’s Economic Playbook

Uncovered Long-Hidden U.S. Resource Reserve In Resurfaced Presentation from Former White House Advisor That Could Quietly Reshape Trump’s Economic Playbook

Washington, D.C., July 04, 2025 (GLOBE NEWSWIRE) -- As political debate intensifies over the cost and scale of President Trump’s sweeping legislative proposal—referred to by insiders as the “Big Beautiful Bill”—a released presentation by Jim...

Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer

Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer

Dr. Charles, Accomplished Immunology-Focused Drug Developer, Brings More Than 20 years of Biopharma Leadership, Clinical Development, and Operations Expertise Company Also Hires Cindy J. Driscoll, MBA, Financial Executive with Over Two Decades of...

Dr. Andrea D. Sullivan Warns: Ozempic and Wegovy Aren’t the Real Solution—The Crisis Is Our Disconnection from Food

Dr. Andrea D. Sullivan Warns: Ozempic and Wegovy Aren’t the Real Solution—The Crisis Is Our Disconnection from Food

Dr. Andrea D. Sullivan urges Americans to rethink the Ozempic craze and address the root cause: a lack of education about food and lifestyle. WASHINGTON, DC, UNITED STATES, June 16, 2025 /⁨EINPresswire.com⁩/ -- As demand for prescription...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Open Lending Corporation, Civitas Resources, and Avis Budget and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Open Lending Corporation, Civitas Resources, and Avis Budget and Encourages Investors to Contact the Firm

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Open Lending Corporation...

U.S. Chamber of Commerce Discusses How Tariffs Will Raise the Cost of Summer Fun with YourUpdateTV

U.S. Chamber of Commerce Discusses How Tariffs Will Raise the Cost of Summer Fun with YourUpdateTV

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- As Americans gear up for summer fun, new analysis from the U.S. Chamber of Commerce reveals that tariffs are quietly raising the prices of warm-weather essentials, from baseball gloves to beach...

RIPPLECOIN Mining launches smart cloud mining app, making crypto income easier than ever

RIPPLECOIN Mining launches smart cloud mining app, making crypto income easier than ever

Washington, D.C, July 04, 2025 (GLOBE NEWSWIRE) -- RIPPLECOIN Mining, the world's leading cloud mining platform, today officially announced the launch of its new mobile cloud mining application, aiming to provide global users with a more...

Released Presentation from Former CIA Advisor Suggests Untapped U.S. Asset Could Quietly Support Trump’s Ambitious Economic Plans

Released Presentation from Former CIA Advisor Suggests Untapped U.S. Asset Could Quietly Support Trump’s Ambitious Economic Plans

Washington, D.C., July 03, 2025 (GLOBE NEWSWIRE) -- As President Trump prepares to unveil what insiders are calling a “Big Beautiful Bill” to reshape America’s industrial and energy backbone, a resurfaced presentation from former Pentagon and...

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next...

Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Securities of Capstone Green Energy Corporation – CGEH

Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Securities of Capstone Green Energy Corporation – CGEH

LOS ANGELES, July 07, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP and The Rosen Law Firm, P.A. announce that the United States District Court for the Central District of California has approved the following announcement of a proposed class action...

Gavin Gassen, M.D. Brings His Expertise to ENT and Allergy Associates’ Poughkeepsie Office

Gavin Gassen, M.D. Brings His Expertise to ENT and Allergy Associates’ Poughkeepsie Office

Tarrytown, New York, June 12, 2025 (GLOBE NEWSWIRE) -- ENT and Allergy Associates, LLP (ENTA), the largest ear, nose, throat, allergy, and audiology practice in the country, is proud to welcome Gavin M. Gassen, M.D., a board-certified...

Christopher C. Witt appointed to State Game Commission

Christopher C. Witt appointed to State Game Commission

SANTA FE – Gov. Michelle Lujan Grisham today announced the appointment of Christopher C. Witt, Ph.D. to the State Game Commission to fill the vacancy in District 5. Christopher C. Witt is a Professor in the Department of Biology at the University...

Amalgamated Bank Advances Climate Leadership with C-PACE Financing for 205kW Solar Energy and Roofing Project in New Bedford

Amalgamated Bank Advances Climate Leadership with C-PACE Financing for 205kW Solar Energy and Roofing Project in New Bedford

NEW BEDFORD, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Amalgamated Bank, a subsidiary of Amalgamated Financial Corp. (Nasdaq: AMAL), today announced the successful closing of a Commercial Property Assessed Clean Energy ("C-PACE") financing under...

2025 Morgan and Peace Uncirculated Silver Dollars Available on July 10

2025 Morgan and Peace Uncirculated Silver Dollars Available on July 10

WASHINGTON, D.C., July 03, 2025 (GLOBE NEWSWIRE) -- The United States Mint (Mint) announces that the 2025 Morgan and Peace Uncirculated Silver Dollars will be available for purchase starting on July 10 at noon (ET). Both struck at the Philadelphia...

vTv Therapeutics to Participate in the H.C. Wainwright “HCW@Home” Series

vTv Therapeutics to Participate in the H.C. Wainwright “HCW@Home” Series

HIGH POINT, N.C., June 11, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin, a potential first-in-class oral adjunctive therapy to insulin being...

OR Royalties Announces Preliminary Q2 2025 GEO Deliveries Along with Record Quarterly Revenue & Cash Margin

OR Royalties Announces Preliminary Q2 2025 GEO Deliveries Along with Record Quarterly Revenue & Cash Margin

MONTRÉAL, July 07, 2025 (GLOBE NEWSWIRE) -- OR Royalties Inc. (“OR Royalties” or the “Company”) (OR: TSX & NYSE) is pleased to provide an update on its second quarter 2025 preliminary deliveries, revenues and cash margin, as well as on its cash...

Wandercraft announces Series D Round, bringing $75M in total funding secured for global acceleration of AI-powered robotics

Wandercraft announces Series D Round, bringing $75M in total funding secured for global acceleration of AI-powered robotics

Clinical progress, industrial partnerships, and global recognition drive momentum in rehabilitation, personal mobility, and humanoid robotics. New agreement with Renault Group accelerates commercialization and advances Wandercraft’s global...

Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

LEXINGTON, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced Alfred W. Sandrock, Jr., M.D., Ph.D., Chief...

Boehringer Ingelheim initiates Phase II study of BI 1815368, a potential first-in-class oral treatment for diabetic macular edema

Boehringer Ingelheim initiates Phase II study of BI 1815368, a potential first-in-class oral treatment for diabetic macular edema

Ingelheim, Germany, July 7, 2025 – Boehringer Ingelheim today announces the start of the THULITE Phase II clinical study (NCT06962839). It will investigate the efficacy, safety and tolerability of BI 1815368 as a potential oral treatment to...

Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development

Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development

WESTLAKE VILLAGE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced the appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance...

VitalHub Announces Acquisition of Novari Health Inc.

VitalHub Announces Acquisition of Novari Health Inc.

TORONTO, July 07, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it has acquired (the “Acquisition”) Novari Health Inc. (“Novari”), a leading healthcare software provider...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service